Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer

Preoperative (chemo)radiotherapy, (C)RT, is an essential part of the treatment of rectal cancer patients, but tumor response to this therapy among patients is variable. Thus far, there are no clinical biomarkers that could be used to predict response to (C)RT or to stratify patients into different p...

Descripción completa

Detalles Bibliográficos
Autores principales: Birkman, Eva‐Maria, Elzagheid, Adam, Jokilehto, Terhi, Avoranta, Tuulia, Korkeila, Eija, Kulmala, Jarmo, Syrjänen, Kari, Westermarck, Jukka, Sundström, Jari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852361/
https://www.ncbi.nlm.nih.gov/pubmed/29441695
http://dx.doi.org/10.1002/cam4.1361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852361/
https://www.ncbi.nlm.nih.gov/pubmed/29441695
http://dx.doi.org/10.1002/cam4.1361

Ejemplares similares